Rights Issue30 May 2026, 01:02 pm
Archean Chemical to Invest ₹170 Cr in Acume Chemicals Rights Issue
AI Summary
Archean Chemical Industries Ltd will invest up to ₹170 crore in its wholly-owned subsidiary, Acume Chemicals Private Limited, by subscribing to its rights issue. The investment, approved by the Board on May 11, 2026, will be made in one or more tranches to strengthen Acume Chemicals' capital base, improve capacity utilization, and reduce external borrowings. As of March 31, 2026, Acume Chemicals had total assets of ₹28,649.78 Lakhs and revenue from operations of ₹8,111.53 Lakhs.
Key Highlights
- Archean Chemical to invest up to ₹170 Cr in Acume Chemicals' rights issue.
- Investment aims to strengthen Acume Chemicals' capital base and reduce borrowings.
- Acume Chemicals' revenue stood at ₹8,111.53 Lakhs as of March 31, 2026.
- The company currently holds 100% of Acume Chemicals and will continue to do so post-issue.
- No separate governmental or regulatory approval is presently required for the investment.
Price Impact
More from ACI